{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:55:32Z","timestamp":1793498132379,"version":"4.5.0"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Catecholamine-producing tumors of childhood include most notably neuroblastoma, but also pheochromocytoma and paraganglioma (PPGL). Diagnosis of the former depends largely on biopsy-dependent histopathology, but this is contraindicated in PPGL where diagnosis depends crucially on biochemical tests of catecholamine excess. Such tests retain some importance in neuroblastoma though continue to largely rely on measurements of homovanillic acid (HVA) and vanillylmandelic acid (VMA), which are no longer recommended for PPGL. For PPGL, urinary or plasma metanephrines are the recommended most accurate tests. Addition of methoxytyramine to the plasma panel is particularly useful to identify dopamine-producing tumors and combined with normetanephrine also shows superior diagnostic performance over HVA and VMA for neuroblastoma. While use of metanephrines and methoxytyramine for diagnosis of PPGL in adults is established, there are numerous pitfalls for use of these tests in children. The establishment of pediatric reference intervals is particularly difficult and complicated by dynamic changes in metabolites during childhood, especially in infants for both plasma and urinary measurements, and extending to adolescence for urinary measurements. Interpretation of test results is further complicated in children by difficulties in following recommended preanalytical precautions. Due to this, the slow growing nature of PPGL and neglected consideration of the tumors in childhood the true pediatric prevalence of PPGL is likely underappreciated. Earlier identification of disease, as facilitated by surveillance programs, may uncover the true prevalence and improve therapeutic outcomes of childhood PPGL. For neuroblastoma there remain considerable obstacles in moving from entrenched to more accurate tests of catecholamine excess.<\/jats:p>","DOI":"10.3389\/fendo.2022.901760","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:52:02Z","timestamp":1658796722000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Graeme","family":"Eisenhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Peitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41588-021-00818-x","article-title":"Single-Cell Transcriptomics of Human Embryos Identifies Multiple Sympathoblast Lineages With Potential Implications for Neuroblastoma Origin","volume":"53","author":"Kameneva","year":"2021","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00806-1","article-title":"Single-Cell Transcriptomic Analyses Provide Insights Into the Developmental Origins of Neuroblastoma","volume":"53","author":"Jansky","year":"2021","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90234-S","article-title":"Serum Vanillylmandelic Acid\/Homovanillic Acid Contributes to Prognosis Estimation in Patients With Localised But Not With Metastatic Neuroblastoma","author":"Berthold","year":"1992","journal-title":"Eur J Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28081","article-title":"Biochemical Testing for Neuroblastoma Using Plasma Free 3-O-Methyldopa, 3-Methoxytyramine, and Normetanephrine","volume":"67","author":"Peitzsch","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00447","article-title":"Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma","volume":"6","author":"Verly","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.01.014","article-title":"Catecholamine Excretion Profiles Identify Clinical Subgroups of Neuroblastoma Patients","volume":"111","author":"Verly","year":"2019","journal-title":"Eur J Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1122\u20131132","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28981","article-title":"Pseudohypoxic Pheochromocytomas and Paragangliomas Dominate in Children","author":"Redlich","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14467","article-title":"Genetic and Clinical Aspects of Paediatric Pheochromocytomas and Paragangliomas","volume":"95","author":"Petenuci","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4158\/EP161377.OR","article-title":"Growth Rate of Paragangliomas Related to Germline Mutations of the Sdhx Genes","volume":"23","author":"Michalowska","year":"2017","journal-title":"Endocr Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12022-016-9452-5","article-title":"Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice","volume":"28","author":"Powers","year":"2017","journal-title":"Endocr Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0651","article-title":"Longitudinal Plasma Metanephrines Preceding Pheochromocytoma Diagnosis: A Retrospective Case-Control Serum Repository Study","volume":"174","author":"Olson","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0318","article-title":"Missed Clinical Clues in Patients With Pheochromocytoma\/Paraganglioma Discovered by Imaging","author":"Rogowski-Lehmann","year":"2018","journal-title":"Endocr Connect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.21612","article-title":"Pheochromocytoma in Children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/000992280504400811","article-title":"Presenting Signs and Symptoms of Pheochromocytoma in Pediatric-Aged Patients","volume":"44","author":"Sullivan","year":"2005","journal-title":"Clin Pediatr (Phila)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2830","article-title":"A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma","volume":"95","author":"Waguespack","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1588","article-title":"Age at Diagnosis of Pheochromocytoma Differs According to Catecholamine Phenotype and Tumor Location","volume":"96","author":"Eisenhofer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel-Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.13926","article-title":"Clinical Practice Guidance: Surveillance for Phaeochromocytoma and Paraganglioma in Paediatric Succinate Dehydrogenase Gene Mutation Carriers","volume":"90","author":"Wong","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0522","article-title":"An Analysis of Surveillance Screening for SDHB-Related Disease in Childhood and Adolescence","volume":"8","author":"Tufton","year":"2019","journal-title":"Endocr Connect"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(92)90396-o","article-title":"Pheochromocytoma in Children: 15 Cases","volume":"27","author":"Revillon","year":"1992","journal-title":"J Pediatr Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28332","article-title":"Pheochromocytomas and Paragangliomas in Children: Data From the Italian Cooperative Study (TREP)","volume":"67","author":"Virgone","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and Paraganglioma: Clinical Feature-Based Disease Probability in Relation to Catecholamine Biochemistry and Reason for Disease Suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1297\/cpe.27.87","article-title":"A Pediatric Case of Pheochromocytoma Without Apparent Hypertension Associated With Von Hippel-Lindau Disease","volume":"27","author":"Igaki","year":"2018","journal-title":"Clin Pediatr Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8446","article-title":"Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma","volume":"87","author":"Weise","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2001.00716.x","article-title":"Asymptomatic Bladder Phaeochromocytoma in a 7-Year-Old Boy","volume":"37","author":"Bonacruz Kazzi","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2005.18.6.527","article-title":"Sporadic Phaeochromocytoma in Childhood: Clinical and Molecular Variability","volume":"18","author":"Pozo","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11239-9","article-title":"Neuroblastoma in Europe: Differences in the Pattern of Disease in the UK. SENSE. Study Group for the Evaluation of Neuroblastoma Screening in Europe","volume":"352","author":"Powell","year":"1998","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.92.3.358","article-title":"Prenatal Detection of Neuroblastoma: A Ten-Year Experience From the Dana-Farber Cancer Institute and Children's Hospital","volume":"92","author":"Ho","year":"1993","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma","volume":"2","author":"Eisenhofer","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine Metabolism: A Contemporary View With Implications for Physiology and Medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma Metanephrines are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within Tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66041565.x","article-title":"Mesenteric Organ Production, Hepatic Metabolism, and Renal Elimination of Norepinephrine and its Metabolites in Humans","volume":"66","author":"Eisenhofer","year":"1996","journal-title":"J Neurochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.10.7559889","article-title":"Regional Release and Removal of Catecholamines and Extraneuronal Metabolism to Metanephrines","volume":"80","author":"Eisenhofer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.11.4339","article-title":"Substantial Production of Dopamine in the Human Gastrointestinal Tract","volume":"82","author":"Eisenhofer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.18.SupplementI_S93","article-title":"Is There a Third Peripheral Catecholaminergic System? Endogenous Dopamine as an Autocrine\/Paracrine Substance Derived From Plasma DOPA and Inactivated by Conjugation","author":"Goldstein","year":"1995","journal-title":"Hypertens Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01210.x","article-title":"Renal Conversion of Plasma DOPA to Urine Dopamine","volume":"12","author":"Brown","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1042\/cs0840549","article-title":"Derivation of Urinary Dopamine From Plasma Dihydroxyphenylalanine in Humans","volume":"84","author":"Wolfovitz","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"B39","article-title":"Tubular Secretion and Metabolism of Dopamine, Norepinephrine, Methoxytyramine and Normetanephrine by the Rat Kidney","volume":"208","author":"Baines","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.7.5864","article-title":"Sources and Physiological Significance of Plasma Dopamine Sulfate","volume":"84","author":"Goldstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/47.6.988","article-title":"Free or Total Metanephrines for Diagnosis of Pheochromocytoma: What is the Difference","volume":"47","author":"Eisenhofer","year":"2001","journal-title":"Clin Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma Versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1210\/jcem-49-3-445","article-title":"The Relationship Between Enzyme Activity and the Catecholamine Content and Secretion of Pheochromocytomas","volume":"49","author":"Feldman","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1557","article-title":"Monoamine Oxidase A Down-Regulation Contributes to High Metanephrine Concentration in Pheochromocytoma","volume":"97","author":"Grouzmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1222\u20131223","DOI":"10.1038\/1961222a0","article-title":"Catechol-O-Methyltransferase Activity in Neuroblastoma Tumour","volume":"196","author":"Labrosse","year":"1962","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/science.160.3829.767","article-title":"Tyramine-H3: Deaminated Metabolites in Neuroblastoma Tumors and in Continuous Cell Line of a Neuroblastoma","volume":"160","author":"Goldstein","year":"1968","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/08880019609033369","article-title":"3,4-Dihydroxyphenylalanine (DOPA) Metabolism in Screening-Detected and non-Screening-Detected Neuroblastoma","volume":"13","author":"Ikeda","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/57.3.633","article-title":"Catecholamine Metabolism in Neuroblastoma","volume":"57","author":"LaBrosse","year":"1976","journal-title":"J Natl Cancer Inst"},{"key":"B49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI104898","article-title":"Turnover and Metabolism of Catecholamines in Patients With Pheochromocytoma","volume":"43","author":"Crout","year":"1964","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"193\u2013212","DOI":"10.1007\/s12022-003-0012-4","article-title":"Pheochromocytoma: Rediscovery as a Catecholamine-Metabolizing Tumor","volume":"14","author":"Eisenhofer","year":"2003","journal-title":"Endocr Pathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1915\u20131915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4158\/EP12050.OR","article-title":"Performance of Plasma Fractionated Free Metanephrines by Enzyme Immunoassay in the Diagnosis of Pheochromocytoma and Paraganglioma in Children","volume":"18","author":"Sarathi","year":"2012","journal-title":"Endocr Pract"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical Diagnosis of Pheochromocytoma: Which Test is Best","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012277","article-title":"Neuroblastoma Screening at One Year of Age","volume":"346","author":"Schilling","year":"2002","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28153","article-title":"Optimization of Percutaneous Biopsy for Diagnosis and Pretreatment Risk Assessment of Neuroblastoma","volume":"67","author":"Overman","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25385","article-title":"Pediatric Reference Intervals for Plasma Free and Total Metanephrines Established With a Parametric Approach: Relevance to the Diagnosis of Neuroblastoma","volume":"62","author":"Franscini","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clinbiochem.2019.02.012","article-title":"Plasma Free Metanephrines for Diagnosis of Neuroblastoma Patients","volume":"66","author":"Barco","year":"2019","journal-title":"Clin Biochem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/0004563216654723","article-title":"Clinical Validation of Urine 3-Methoxytyramine as a Biomarker of Neuroblastoma and Comparison With Other Catecholamine-Related Biomarkers","volume":"54","author":"Lam","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(89)90386-6","article-title":"Combined Measurements of Plasma Aromatic L-Amino Acid Decarboxylase and DOPA as Tumour Markers in Diagnosis and Follow-Up of Neuroblastoma","volume":"25","author":"Boomsma","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.03.1620","article-title":"Age-Specific Pediatric Reference Intervals for Plasma Free Normetanephrine, Metanephrine, 3-Methoxytyramine and 3-O-Methyldopa: Particular Importance for Early Infancy","volume":"494","author":"Peitzsch","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0009-8981(95)06031-1","article-title":"Urinary Creatinine Adjusted Reference Ranges for Homovanillic and Vanillylmandelic Acid in Children and Adults","volume":"236","author":"Cole","year":"1995","journal-title":"Clin Chim Acta"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2008.10.022","article-title":"Reference Intervals for Urinary Catecholamines and Metabolites From Birth to Adulthood","volume":"42","author":"Pussard","year":"2009","journal-title":"Clin Biochem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011023","article-title":"Age-Related Medical Decision Limits for Urinary Free (Unconjugated) Metadrenalines, Catecholamines and Metabolites in Random Urine Specimens From Children","volume":"48","author":"Davidson","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2010.010062","article-title":"Establishment of a Paediatric Age-Related Reference Interval for the Measurement of Urinary Total Fractionated Metanephrines","volume":"48","author":"Griffin","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.04.015","article-title":"Urinary Homovanillic and Vanillylmandelic Acid in the Diagnosis of Neuroblastoma: Report From the Italian Cooperative Group for Neuroblastoma","volume":"47","author":"Barco","year":"2014","journal-title":"Clin Biochem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.6.863","article-title":"Total-Body Skeletal Muscle Mass: Evaluation of 24-H Urinary Creatinine Excretion by Computerized Axial Tomography","volume":"63","author":"Wang","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1990.tb11404.x","article-title":"Urinary Creatinine Excretion and Estimation of Muscle Mass in Infants of 25-34 Weeks Gestation","volume":"79","author":"Modi","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"B68","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/adc.63.4.398","article-title":"Urinary Creatinine Excretion in the Newborn","volume":"63","author":"Al-Dahhan","year":"1988","journal-title":"Arch Dis Child"},{"key":"B69","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/BF01957912","article-title":"Changes in the Urinary Excretion of Creatinine, Albumin and N-Acetyl-Beta-D-Glucosaminidase With Increasing Age and Maturity in Healthy Schoolchildren","volume":"155","author":"Skinner","year":"1996","journal-title":"Eur J Pediatr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0730","article-title":"Measurements of Plasma Metanephrines by Immunoassay vs Liquid Chromatography With Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma","volume":"172","author":"Weismann","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvab060","article-title":"Harmonization of LC-MS\/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine","volume":"67","author":"Peitzsch","year":"2021","journal-title":"Clin Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.05.024","article-title":"Liquid Chromatography Tandem Mass Spectrometry for Plasma Metadrenalines","volume":"495","author":"Davies","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.amjmed.2021.03.015","article-title":"Inpatient Measurements of Urine Metanephrines are Indistinguishable From Pheochromocytoma: Retrospective Cohort Study","volume":"134","author":"Kline","year":"2021","journal-title":"Am J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/EJE-19-1016","article-title":"Overnight\/first-Morning Urine Free Metanephrines and Methoxytyramine for Diagnosis of Pheochromocytoma and Paraganglioma: Is This an Option","volume":"182","author":"Peitzsch","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0022","article-title":"Blood Sampling for Metanephrines Comparing Venipuncture vs. Indwelling Intravenous Cannula in Healthy Subjects","volume":"58","author":"Eijkelenkamp","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.0c01263","article-title":"In Matrix Derivatization Combined With LC-MS\/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines","volume":"92","author":"van Faassen","year":"2020","journal-title":"Anal Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary Influences on Plasma and Urinary Metanephrines: Implications for Diagnosis of Catecholamine-Producing Tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2020.021003","article-title":"Case Report of a Phantom Pheochromocytoma","volume":"30","author":"Joyce","year":"2020","journal-title":"Biochem Med (Zagreb)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma Methoxytyramine: A Novel Biomarker of Metastatic Pheochromocytoma and Paraganglioma in Relation to Established Risk Factors of Tumour Size, Location and SDHB Mutation Status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0904","article-title":"Plasma Metanephrines and Prospective Prediction of Tumor Location, Size and Mutation Type in Patients With Pheochromocytoma and Paraganglioma","volume":"59","author":"Eisenhofer","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.918435","article-title":"Adrenocortical Tumors and Pheochromocytoma\/Paraganglioma Initially Mistaken as Neuroblastoma \u2013 Experiences From the GPOH-MET Registry","author":"Kuhlen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.145.1.113","article-title":"Fine-Needle Aspiration of Catecholamine-Producing Adrenal Masses: A Possibly Fatal Mistake","volume":"145","author":"McCorkell","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.surg.2007.07.013","article-title":"Needle Biopsy of Incidentally Discovered Adrenal Masses is Rarely Informative and Potentially Hazardous","volume":"142","author":"Quayle","year":"2007","journal-title":"Surgery"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2000.00504.x","article-title":"The Perioperative Management of Children With Phaeochromocytoma","volume":"10","author":"Hack","year":"2000","journal-title":"Paediatr Anaesth"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2005.11.024","article-title":"Composite Pheochromocytoma Associated With Adrenal Neuroblastoma in an Infant: A Case Report","volume":"41","author":"Tatekawa","year":"2006","journal-title":"J Pediatr Surg"},{"key":"B86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1309\/AJCPN76VTIGWPOAG","article-title":"Composite Pheochromocytoma: A Clinicopathologic and Molecular Comparison With Ordinary Pheochromocytoma and Neuroblastoma","volume":"132","author":"Comstock","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2225-9","article-title":"Composite Tumor With Pheochromocytoma and Immature Neuroblastoma: Report of Two Cases With Cytogenetic Analysis and Discussion of Current Terminology","volume":"471","author":"Tran","year":"2017","journal-title":"Virchows Arch"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple Endocrine Tumors Associated With Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609263","article-title":"Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant","volume":"12","author":"Duarte","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201000089","article-title":"An Integrated Proteomic Approach to Identifying Circulating Biomarkers in High-Risk Neuroblastoma and Their Potential in Relapse Monitoring","volume":"5","author":"Egler","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"B91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2021.09.022","article-title":"The Feasibility of Using Liquid Biopsies as a Complementary Assay for Copy Number Aberration Profiling in Routinely Collected Paediatric Cancer Patient Samples","volume":"160","author":"Van Paemel","year":"2022","journal-title":"Eur J Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00431-019-03545-y","article-title":"The Pitfalls and Promise of Liquid Biopsies for Diagnosing and Treating Solid Tumors in Children: A Review","volume":"179","author":"Van Paemel","year":"2020","journal-title":"Eur J Pediatr"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02213-x","article-title":"Imaging Features of Adrenal Gland Masses in the Pediatric Population","volume":"45","author":"Hanafy","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02932620","article-title":"Calcified Adrenal Masses","volume":"9","author":"Kenney","year":"1987","journal-title":"Urol Radiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-018-4117-9","article-title":"A Review of Neuroblastoma Image-Defined Risk Factors on Magnetic Resonance Imaging","volume":"48","author":"Chen","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3192","article-title":"Peak Incidence of Pheochromocytoma and Primary Hyperparathyroidism in Multiple Endocrine Neoplasia 2: Need for Age-Adjusted Biochemical Screening","volume":"98","author":"Machens","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and Paraganglioma in Patients With Neurofibromatosis Type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1353.003","article-title":"Characteristics of Pheochromocytoma in a 4- to 20-Year-Old Population","volume":"1073","author":"Barontini","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3109\/08880019709028771","article-title":"Pheochromocytoma and Paraganglioma in Children: A Report of 24 Cases of the French Society of Pediatric Oncology","volume":"14","author":"Perel","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.3390\/molecules26113470","article-title":"Application of an LC-MS\/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients","volume":"26","author":"Hwang","year":"2021","journal-title":"Molecules"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20888","article-title":"Diagnostic and Prognostic Impact of Urinary Catecholamines in Neuroblastoma Patients","volume":"48","author":"Strenger","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1175-1","article-title":"Comparative Values of Catecholamines and Metabolites for the Diagnosis of Neuroblastoma","volume":"162","author":"Monsaingeon","year":"2003","journal-title":"Eur J Pediatr"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200306","article-title":"Methylated Catecholamine Metabolites for Diagnosis of Neuroblastoma","volume":"20","author":"Candito","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"B104","doi-asserted-by":"crossref","DOI":"10.1542\/peds.79.2.203","article-title":"Three Years of Experience With Random Urinary Homovanillic and Vanillylmandelic Acid Levels in the Diagnosis of Neuroblastoma","volume":"79","author":"Tuchman","year":"1987","journal-title":"Pediatrics"},{"key":"B105","article-title":"Urinary Excretion of 3-Methoxy-4-Hydroxymandelic Acid and 3-Methoxy-4-Hydroxyphenylacetic Acid by 288 Patients With Neuroblastoma and Related Neural Crest Tumors","volume":"40","author":"LaBrosse","year":"1980","journal-title":"Cancer Res"},{"key":"B106","first-page":"1421","article-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","author":"Rifai","year":"2018"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(96)00361-9","article-title":"Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria","author":"Kerbl","year":"1996","journal-title":"Eur J Cancer"},{"key":"B108","doi-asserted-by":"crossref","DOI":"10.1542\/peds.75.2.324","article-title":"Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections","volume":"75","author":"Tuchman","year":"1985","journal-title":"Pediatrics"},{"key":"B109","article-title":"Excretion of catecholamine catabolites by normal children","volume":"72","author":"Gitlow","year":"1968","journal-title":"J Lab Clin Med"},{"key":"B110","article-title":"Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid","volume":"39","author":"Voorhess","year":"1967","journal-title":"Pediatrics"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.901760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:52:10Z","timestamp":1658796730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.901760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":110,"alternative-id":["10.3389\/fendo.2022.901760"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.901760","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"901760"}}